Research at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.
|Articles|November 23, 2011
Report: U.S. Outspends Other Countries On Health Care
Advertisement
The Organization for Economic Co-operation and Development’s (OECD) Health at a glance 2011 report proved that the US once again ranks as the number one spending country on healthcare.
Out of the OECD’s 34 member countries the US has the highest cost of medical care and administrative costs which is about 7 percent on healthcare costs. This year’s study showed that the United States spent around $7,960 per person on health care in 2009 —2.5 times the average of the countries studied.
Read more at: http://capsules.kaiserhealthnews.org/index.php/2011/11/report-u-s-outspends-other-countries-on-health-care/
Source: Kaiser Health News
Advertisement
Related to this article
In 459 patients with FLT3-ITD AML given high-dose anthracycline induction, a high allelic ratio was not linked to survival.
From 9.6 million US diabetic retinopathy cases to a new FDA warning on GLP-1s, here are 5 things to know about diabetic eye disease this November.
New CMS data let EBRI measure what employer plans owe after No Surprises Act arbitration: $8.39B in 2025, though premium impact is unclear.
A new meta-analysis finds pulmonary rehabilitation and other nonpharmacological interventions ease lung cancer cough, dyspnea, and improve QOL.
Machine learning models for upper extremity soft tissue sarcoma had a C-index of 0.79 for local recurrence, similar to nomograms, in a 188-patient cohort.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
2
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
3
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
4
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
5